ITC Investigating Chinese Biopharma Chemicals Over Pricing
The U.S. International Trade Commission is looking into whether Chinese imports of two chemicals used in biopharma manufacturing that are allegedly being sold at unfair prices are harming U.S. domestic industry,...To view the full article, register now.
Already a subscriber? Click here to view full article